Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000149

EVP and CMO sold 2,329 shares at $450.95 ($1,050,263)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bozic Carmen · EVP and CMO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-27 Sale : show line 1 in the form 10b5-1 −2,329 $450.95 $1,050,263 33,076 D
Open-market sales · 2,329 sh · avg $450.95 · $1,050,263
Loading xslF345X06/wk-form4_1774987818.xml…